Ypsomed Holding AG
YPSN
Kedudukan dalam Saham
#2943
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Harga Saham
$468.66
Modal Pasaran
$6.16B
Perubahan (1 hari)
1.47%
Perubahan (1 tahun)
18.80%
Negara
CH
Perdagangan Ypsomed Holding AG (YPSN)
Kategori
Healthcare
Nisbah P/E bagi Ypsomed Holding AG (YPSN)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Ypsomed Holding AG, nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi Ypsomed Holding AG dari 2002 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2025 | 52.96 | -14.36% |
| 2024 | 61.85 | 22.83% |
| 2023 | 50.35 | -43.56% |
| 2022 | 89.21 | -74.08% |
| 2021 | 344.22 | 156.38% |
| 2020 | 134.26 | 397.39% |
| 2019 | 26.99 | -23.24% |
| 2018 | 35.17 | -32.11% |
| 2017 | 51.80 | 7.19% |
| 2016 | 48.33 | -18.25% |
| 2015 | 59.12 | -17.99% |
| 2014 | 72.08 | -82.56% |
| 2013 | 413.31 | 406.81% |
| 2012 | 81.55 | -40.99% |
| 2011 | 138.21 | 59.97% |
| 2010 | 86.40 | 183.61% |
| 2009 | 30.46 | -15.15% |
| 2008 | 35.90 | -90.80% |
| 2007 | 390.29 | 859.06% |
| 2006 | 40.70 | 23.88% |
| 2005 | 32.85 | 103.69% |
| 2004 | 16.13 | 3.77% |
| 2003 | 15.54 | -89.36% |
| 2002 | 146.00 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 26.50 | - |
IE
|
|
| 81.39 | - |
CN
|
|
| - | - |
CH
|
|
| 22.17 | - |
CN
|
|
| 19.80 | - |
KR
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.